Keywords: connective, begins, trials, ms, vaccine, therapeutics, commenced
Connective Begins Trials With MS Vaccine
Article | 20 January 1997
Connective Therapeutics has commenced a Phase I/II clinical trial withits T cell receptor peptide vaccine for multiple sclerosis.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
